Home > Press > Applied Nanotech Expands Executive Team to Drive Commercialization Momentum
Abstract:
Appoints VP of Business Development and Director of Business Development
Applied Nanotech Holdings, Inc. /quotes/comstock/11k!apnt (APNT 0.28, -0.01, -3.45%) is pleased to announce that as part of its near and long-term commercialization strategy, it has named Dr. Samuel Kim as Vice-President of Business Development and hired Shahar Bar-Cohav as Director of Business Development.
Dr. Kim, who has been with APNT since February 2009, has both Bachelor of Science and Master of Science degrees in mechanical engineering from Stanford University and a Dual PhD in Electrical Engineering and Nanotechnology from the University of Washington. Dr. Kim has over 9 years of experience in high technology venture formation with several startups in the biotechnology, medical devices, semiconductors, and automotive industries. The depth of his technical expertise coupled with his business background is very instrumental to shape the future direction of Applied Nanotech toward technology commercialization.
Shahar Bar-Cohav has a Master of Business Administration degree from the Stephen M. Ross School of Business at the University of Michigan-Ann Arbor, with emphases in marketing and corporate strategy, and a law degree (magna cum laude) from Tel Aviv University. Prior to joining APNT, Mr. Bar-Cohav practiced law for four years as a commercial attorney, specializing in licensing, joint-venture, investment transactions, and due diligence investigations. In addition, Mr. Bar-Cohav completed marketing and business development consulting projects for Baxter Healthcare Corporation, and Bristol-Myers Squibb, relating to the launch of new products, and identification of new markets and commercial collaboration opportunities,
"Our unique approach to nanotechnology and the excellent R&D results that we have achieved thus far have brought us to the point of needing focused commercialization efforts for our technologies. Enhancing our team with Sam and Shahar underlines our continued growth and steadfast performance in driving commercialization of our technologies, " said Dr. Zvi Yaniv, president/CEO of ANI.
"We are thrilled to have two such highly qualified professionals leading our business development effort," said Doug Baker, CEO of APNT. "We are increasing our focus on business development and commercializing our technologies. Sam and Shahar's skills and experience will be very valuable to us in this effort."
APNT has also posted a brief shareholder letter primarily related to the upcoming shareholders meeting on its website at www.appliednanotech.net.
Safe Harbor Statement
This release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2009, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.
####
About Applied Nanotech
APNT is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending.
For more information, please click here
Contacts:
Applied Nanotech Holdings, Inc.
Doug Baker
1.248.391.0612
Copyright © Applied Nanotech
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Appointments/Promotions/New hires/Resignations/Deaths
Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021
JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021
The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||